How IRDAI's 2025 Brokerage and Commission Reforms Affect Commercial Insurance Buyers

For more than two decades, insurance broker commissions in India were governed by a rigid cap. IRDAI's Insurance Brokers Regulations, as originally framed, prescribed maximum brokerage rates that brokers could earn: typically 12.5% for non-life insurance and lower rates for life and reinsurance business. These caps applied uniformly, regardless of the complexity of the placement, the amount of advisory work involved, or the size of the premium. A broker placing a straightforward group health policy for INR 50 lakh earned commission at the same maximum rate as a broker structuring a multi-layered property programme for an INR 500 crore manufacturing group, despite the latter requiring months of risk engineering, market negotiation, and programme design.

The 2025 amendments, formally introduced through IRDAI's revised Insurance Intermediaries Regulations and supporting circulars, fundamentally altered this structure. The fixed brokerage cap has been replaced with a flexible commission framework that permits insurers and brokers to negotiate commission rates based on the nature, complexity, and volume of business placed.

The key regulatory changes are as follows.

First, the elimination of the prescriptive brokerage ceiling. Under the new framework, there is no hard cap on the brokerage percentage that an insurer may pay to a broker for placing commercial insurance business. The commission is now a matter of commercial negotiation between the insurer and the broker, subject to the requirement that the total acquisition cost (commission plus other expenses) remains within the insurer's overall expense of management (EOM) limits set by IRDAI.

Second, the introduction of insurer-level expense management as the primary control mechanism. Rather than capping individual commission rates, IRDAI now regulates the total expenses of management at the insurer level. Each general insurer has an EOM ceiling expressed as a percentage of gross written premium. The insurer can allocate its expense budget across distribution channels as it sees fit: paying higher commissions to brokers for complex commercial placements while paying lower commissions on high-volume, low-touch retail products. This approach mirrors the regulatory framework used in mature insurance markets such as the UK and Australia.

Third, the requirement for commission agreements. Insurers and brokers are now required to enter into written commission agreements that specify the commission rate, payment terms, and any volume-based or performance-based commission arrangements. These agreements must be disclosed to IRDAI and are subject to audit.

Fourth, the explicit permission for contingent or profit commission arrangements. Under the old regulations, contingent commissions (where the broker earns additional commission based on the profitability of the business placed with a particular insurer) were not explicitly permitted and were treated with regulatory suspicion. The 2025 framework expressly permits such arrangements, provided they are disclosed to the client.

The practical effect of these changes on the commercial insurance market has been significant. For large, complex placements involving property programmes, liability towers, or multi-class packages, brokers can now negotiate commission rates that reflect the actual work involved. A broker spending 200 hours on risk engineering, market negotiation, and programme design for a INR 5 crore premium placement can negotiate a commission that compensates for that effort, rather than being constrained to the same flat percentage earned on a commodity product requiring minimal work.

Conversely, for simple, high-volume commercial products (standard fire policies, group health renewals, motor fleet covers), the competitive dynamic has driven commission rates down. Insurers, freed from the obligation to pay up to the cap, are offering lower commissions on products where the broker adds less value, and brokers competing for volume business are accepting lower rates to win mandates.

The transition has not been without friction. Several industry bodies, including the Insurance Brokers Association of India (IBAI), initially expressed concern that unrestricted commission competition would lead to a race to the top on remuneration, with insurers loading higher commissions into premiums and passing the cost to policyholders. IRDAI's response was to emphasise that the EOM ceiling acts as a natural restraint: an insurer that pays excessive commissions to brokers will either have to reduce other operational expenses or will breach its EOM limit and face regulatory action. In practice, this means the system is self-correcting at the insurer level, but individual placements can still carry commission rates that raise questions about whether the policyholder's premium is being inflated to fund the broker's compensation.

Another dimension of the reform is the explicit recognition of different types of remuneration. The 2025 framework distinguishes between commission (paid by the insurer as a percentage of premium), fees (paid by the client directly to the broker for advisory services), and contingent commissions (paid by the insurer based on portfolio profitability or volume targets). Under the old regime, the boundaries between these categories were blurred, and some arrangements that were effectively contingent commissions operated without formal regulatory recognition. The new framework brings all three categories under explicit regulation, with distinct disclosure requirements for each.

The net result is a more differentiated commission structure that, in theory, aligns broker compensation with broker value-add. But as the subsequent sections discuss, this same flexibility introduces new risks for insurance buyers.

Alongside the shift to flexible commissions, IRDAI introduced enhanced disclosure requirements designed to give insurance buyers visibility into how their brokers are compensated. These disclosure requirements are the regulatory counterweight to commission flexibility: if brokers can earn variable commissions from different insurers, buyers must be able to see those variations to assess whether their broker's recommendation is genuinely in their interest.

The disclosure requirements operate at three levels.

Level one: pre-placement disclosure. Before placing a commercial insurance policy, the broker must now provide the client with a written statement disclosing the commission rate(s) it expects to receive from the insurer(s) to which the business is being offered. Where the broker is submitting the risk to multiple insurers (as is standard practice in complex commercial placements), the disclosure must show the expected commission from each insurer on the panel. This allows the buyer to see whether the broker's recommended insurer is also the one offering the highest commission.

The pre-placement disclosure must also include any contingent, profit-share, or volume-based commission arrangements that the broker has with the insurers being approached. If a broker earns a 2% profit commission from Insurer A when the loss ratio on its portfolio stays below 50%, and no such arrangement exists with Insurer B, the buyer has a right to know this before accepting the broker's recommendation of Insurer A.

Level two: post-placement confirmation. After the policy is placed, the broker must provide the client with a confirmation stating the actual commission earned on the placement. This requirement exists because the pre-placement disclosure is based on expected commission rates, which may change during the negotiation. The final commission may differ from the initial disclosure, for example, if the broker negotiated a premium reduction that affected the commission calculation, or if the insurer applied a different commission rate to the layer or section of cover that was ultimately bound.

Level three: annual portfolio disclosure. For clients with ongoing broker relationships (which is the norm in commercial insurance, where broker mandates typically extend across multiple policy years), the broker must provide an annual statement summarising the total commission earned across all policies placed for that client during the preceding year. This portfolio-level view allows the buyer to assess the total cost of intermediation and compare it against the value received.

The disclosure requirements apply to all licensed insurance brokers in India, whether direct brokers, composite brokers, or reinsurance brokers acting on direct placement business. They do not, however, apply to corporate agents or individual agents, who operate under a different regulatory framework with their own (and generally less stringent) disclosure obligations. This creates an asymmetry: a buyer using a broker receives full commission transparency, while a buyer using a corporate agent may not.

For commercial insurance buyers, the practical implications of these disclosure requirements are substantial. For the first time, a CFO or risk manager in India can compare the commission earned by the broker on each insurer's quotation and evaluate whether the broker's recommendation aligns with the buyer's interest or the broker's income. This is not theoretical; it changes the dynamic of every renewal meeting and every competitive tender.

However, disclosure is only as useful as the buyer's ability to interpret it. A commission disclosure showing that the broker earns 15% from Insurer A and 10% from Insurer B is meaningful only if the buyer can assess whether the difference in commission reflects a difference in value (perhaps Insurer A's product requires more servicing, justifying the higher commission) or a difference in alignment (perhaps Insurer A simply pays more to attract business). Without insurance expertise on the buyer's side, the disclosure can become noise rather than signal.

There is also a timing challenge. The pre-placement disclosure is most useful when the buyer receives it early enough in the renewal process to evaluate alternatives. If the disclosure arrives two days before the policy inception date, alongside a recommendation to bind with a specific insurer, the buyer has no practical ability to challenge the recommendation or seek alternative placements. Best practice is for buyers to request the pre-placement disclosure at least 30 days before the renewal date, as part of the structured renewal timeline.

There is also a question of what the disclosure requirements do not cover. The regulations mandate disclosure of commission and remuneration arrangements, but they do not require brokers to disclose non-monetary benefits received from insurers: sponsored conferences, training programmes, technology platforms provided at no cost, or other forms of soft influence that may affect placement decisions without appearing in any commission schedule. These non-monetary benefits are common in the Indian insurance market and, while individually modest, can cumulatively create a preference for particular insurers that the disclosure requirements do not capture. Buyers aware of this limitation should ask their brokers directly about non-monetary relationships with the insurers being proposed.

Enforcement of the disclosure requirements is handled through IRDAI's inspection and audit mechanisms. Brokers are required to maintain records of all disclosures provided to clients, and these records are subject to review during IRDAI's periodic inspections of broking firms. Non-compliance can result in regulatory action ranging from a warning letter to suspension of the broker's licence. The Insurance Brokers Association of India (IBAI) has also published guidance notes on disclosure best practices, though compliance with IBAI guidance is voluntary.

The central concern with flexible commission structures, in any insurance market, is placement steering: the risk that brokers will direct business to the insurer paying the highest commission rather than the insurer offering the best coverage and price for the client. This is not a theoretical concern. International experience from markets that have gone through similar deregulation, notably the UK market following the Financial Services Authority's review of general insurance brokers in 2005 and the Australian market following ASIC's review of conflicted remuneration in financial services, shows that commission flexibility, without adequate controls, leads to measurable shifts in placement patterns.

In India, the risk of placement steering is amplified by three market characteristics.

First, the Indian general insurance market has 30+ insurers competing for commercial business, with significant variation in commission levels. Public sector insurers (New India, United India, National, Oriental) have traditionally paid lower brokerage rates due to internal expense constraints, while private sector insurers, particularly those building market share, have been willing to pay higher commissions to attract business from brokers. Under the old capped regime, this variation was limited by the ceiling. Under the new flexible regime, the spread has widened. Market intelligence from 2025-2026 placement cycles suggests that commission rates on standard commercial property insurance now range from 8% (large public sector insurer, high-volume client) to 20% or more (mid-size private insurer, new-to-market product). This spread creates a material financial incentive for a broker to steer business toward the higher-paying insurer.

Second, most commercial insurance buyers in India do not have dedicated insurance professionals on their staff. The CFO or finance manager handles insurance alongside dozens of other responsibilities. This means the buyer is heavily reliant on the broker's expertise and recommendation, and is poorly positioned to independently evaluate whether the broker's placement advice is influenced by commission considerations. In contrast, large multinational corporations typically employ risk managers who can interrogate broker recommendations, request competing quotations, and evaluate policy wordings independently.

Third, the Indian market has limited price transparency for commercial insurance. Unlike personal lines (motor, health) where premium comparison platforms provide instant visibility, commercial insurance pricing is opaque. The buyer does not know what other companies of similar size and risk profile are paying for equivalent coverage. This opacity makes it difficult for the buyer to detect steering, because they cannot tell whether the premium they are paying is market-competitive or inflated by a commission load.

The regulatory safeguards against placement steering are the disclosure requirements discussed in the previous section, combined with the broker's existing duty of care under the Insurance Brokers Regulations. A broker is legally required to act in the best interest of the client, not the insurer. This duty of care, codified in IRDAI's regulations and reinforced by the Insurance Act, obligates the broker to recommend the insurer that offers the best combination of coverage, price, financial strength, and claims service for the client's specific needs.

But the duty of care is a legal standard enforced through complaints and litigation, not a real-time market mechanism. A buyer who suspects that their broker steered their placement for commission reasons would need to file a complaint with IRDAI or pursue the matter through the courts, a process that takes years and requires evidence that the broker's recommendation was motivated by commission rather than client interest. This evidentiary burden is high, because the broker can always point to legitimate reasons for recommending a particular insurer: better policy wording, stronger claims track record, willingness to provide risk engineering services.

What can buyers do to protect themselves? Several practical steps are available.

Establish a formal broker mandate letter that specifies the number of insurers the broker must approach for each placement (a minimum of three competitive quotations is standard practice), the criteria for evaluating quotations (coverage breadth, price, insurer financial rating, claims experience), and the requirement for a written recommendation report explaining why the recommended insurer was selected.

Request the broker's commission disclosure alongside the quotation comparison. Review the disclosure for patterns: if the broker consistently recommends the insurer paying the highest commission, across multiple policy classes and multiple renewal cycles, this is a red flag.

Consider using a broker remuneration model that reduces the incentive to steer. Fee-based remuneration, where the buyer pays the broker a fixed fee for advisory services and the broker remits all commission received from insurers back to the buyer (as a premium credit), eliminates the commission conflict entirely. Fee-based arrangements are uncommon in the Indian mid-market but are used by large corporates and public sector undertakings. Under the 2025 reforms, IRDAI has expressly permitted fee-based models alongside commission-based models, giving buyers a choice.

Engage a second broker or independent consultant to provide a periodic review of the placement. This 'shadow broking' arrangement, where a second broker reviews the incumbent's work without actually placing the business, provides an independent check on whether the placement was market-competitive and whether the commission structure influenced the recommendation. The cost of a shadow review is modest relative to the premium at stake on a large commercial programme.

IRDAI's commission reforms do not exist in isolation. They are part of a broader transformation of India's insurance regulatory framework that includes the composite licence, which permits a single insurance company to underwrite both life and non-life business from the same entity. The interaction between commission flexibility and the composite licence creates implications that commercial insurance buyers need to understand.

Under the old regulatory framework, life insurance and general insurance were strictly separated. An insurer could underwrite one or the other, not both. This separation extended to distribution: brokers could place both life and general insurance, but the commission structures, regulatory oversight, and market dynamics for the two segments were distinct. A broker's general insurance practice and life insurance practice operated as effectively separate businesses, even within the same broking firm.

The composite licence framework, introduced through the Insurance Laws (Amendment) Act and operationalised by IRDAI through a series of circulars in 2024-2025, permits existing insurers to apply for a composite licence that enables them to offer both life and general insurance products. Several large insurers have applied for or received composite licences, creating entities that can offer group life insurance, group health, property, liability, engineering, and marine covers all from a single balance sheet.

For brokers, the composite insurer creates new opportunities and new conflicts. A broker managing a large corporate client's insurance portfolio, which might include group term life, group health, property, liability, and directors' and officers' cover, can now consolidate all of these lines with a single composite insurer. The benefits are real: simplified administration, a single point of contact for claims across all lines, potential premium discounts for bundled placements, and reduced programme administration costs.

But consolidation also concentrates counterparty risk and amplifies the commission conflict. If a composite insurer offers the broker a portfolio-level commission deal (e.g., a 2% bonus commission on the total premium across all lines if the broker places all five policy classes with that insurer), the broker has a strong financial incentive to consolidate the placement, even if the composite insurer is not the best market for every individual line. The broker might earn an additional INR 10-20 lakh on a large portfolio by consolidating with one insurer, which could compromise the objectivity of the recommendation on lines where a specialist insurer offers better terms.

The IRDAI regulations address this concern partially through the disclosure requirements: the broker must disclose all commission arrangements, including portfolio-level incentives, to the client. But disclosure alone may not be sufficient. The buyer must also understand the trade-off being made: is the premium discount from bundling worth the potential coverage compromise on individual lines?

For mid-market companies, which constitute the bulk of India's commercial insurance buyers, the composite licence creates a double-edged situation. On one hand, they gain access to one-stop insurance solutions that were previously available only through complex multi-insurer programmes requiring specialist broker expertise. A mid-market manufacturer in Pune with INR 1-2 crore total premium can now get a single composite proposal covering fire, engineering, liability, group health, and group term life, with a single policy schedule and a single renewal date. The simplicity is genuinely valuable for companies without dedicated risk management staff.

On the other hand, mid-market companies are least equipped to evaluate whether the bundled solution is truly competitive on each line. A composite insurer may offer a compelling overall package while embedding above-market pricing on one or two lines, effectively subsidising the discount on the other lines. Without line-by-line benchmarking, which requires market knowledge and access to competing quotations, the buyer cannot detect this cross-subsidy.

The interaction between commission reform and the composite licence also affects broker business models. Broking firms that previously specialised in non-life commercial insurance now face an incentive to build or acquire life insurance capabilities, so they can serve the full wallet of the composite insurer's product range. This is driving consolidation in the Indian broking market, with larger firms acquiring smaller specialists. For insurance buyers, broker consolidation has mixed implications: larger broking firms offer broader capabilities and stronger insurer relationships, but they also carry more complex commission arrangements and a higher risk of institutional conflicts of interest.

The practical advice for commercial insurance buyers working through this intersection is straightforward. First, if a broker recommends consolidating all lines with a single composite insurer, request a line-by-line comparison showing each individual product's premium and coverage against the best available alternative from a specialist insurer. The bundled discount should be evaluated as a net benefit only after confirming that no individual line is significantly worse than the market alternative. Second, ask the broker to disclose any portfolio-level or multi-line commission incentives they receive from the composite insurer. Third, consider retaining separate brokers for life and non-life lines if the combined placement raises conflict concerns, notwithstanding the administrative simplicity of using one broker for everything.

The brokerage reforms and composite licence framework are already shaping the renewal experience for mid-market commercial insurance buyers in India. A mid-market company, for the purposes of this discussion, means a business with total annual insurance premium in the range of INR 25 lakh to INR 5 crore, covering a mix of property, liability, health, and possibly marine and engineering lines. This segment represents the largest number of commercial insurance buyers in India and the segment most affected by changes in distribution economics.

Here is what is changing at renewal time, and what mid-market buyers should watch for.

The first visible change is more aggressive broker competition. Under the capped commission regime, brokers competing for a mid-market client could differentiate only on service quality and coverage advice, since the commission was the same regardless of which broker placed the business. Under the flexible regime, brokers can now offer to rebate a portion of their commission back to the client as a premium discount, effectively using commission flexibility as a competitive tool. This is positive for buyers in the short term: the rebate reduces the net premium. But buyers should scrutinise what they lose when the broker cuts its own income. A broker accepting a lower commission may reduce the service level: fewer policy reviews, less rigorous claims advocacy, less frequent risk survey visits. The cheapest broker is not necessarily the best broker.

The second change is a shift in who approaches you. Under the old regime, mid-market companies were served primarily by local brokers or corporate agents with established relationships. The flexible commission structure has made mid-market business more attractive to larger national broking firms, which can negotiate higher commissions from insurers based on their aggregated portfolio volume. Mid-market companies may find themselves approached by broking firms they have never heard of, offering premium savings that seem too good to be true. These approaches are worth evaluating, but buyers should verify the broker's IRDAI licence, check their claims servicing capability (not just their placement capability), and request references from existing commercial clients of similar size and industry.

The third change is the emergence of fee-based advisory models for mid-market clients. Previously, fee-based insurance advisory was the domain of large corporates working with global broking firms. The 2025 reforms have legitimised fee-based models across the market, and some Indian broking firms are now offering mid-market clients a choice: pay a fixed advisory fee (typically INR 2-5 lakh per year for a mid-market portfolio) and receive all insurer commission as a premium credit, or continue with the traditional commission-based model. The fee-based model is worth considering for companies whose total premium exceeds INR 1 crore, because the commission credit often exceeds the advisory fee. For smaller portfolios, the commission amounts may not justify the administrative overhead of a fee-based arrangement.

The fourth change is more detailed renewal documentation. The enhanced disclosure requirements mean that your broker must now provide written commission disclosure before placement and a confirmation after placement. Some brokers are treating this as a compliance exercise, producing disclosure documents that are technically compliant but practically uninformative (disclosing commission as a range rather than a specific rate, or bundling all lines into a single aggregate figure). Buyers should insist on line-by-line disclosure showing the specific commission rate for each policy class, from each insurer on the panel. This is the only format that allows meaningful evaluation of potential conflicts.

The fifth change is in the quotation process itself. Under the old regime, where commissions were capped, the premium quoted by the insurer to the broker was close to the net premium (before commission) plus a known commission percentage. Under the flexible regime, the same insurer may quote different gross premiums to different brokers, depending on the commission arrangement. This means comparing quotations obtained by different brokers is no longer an apples-to-apples exercise. If Broker A has a 15% commission deal with Insurer X and Broker B has a 10% deal with the same insurer, they will present different premiums for the same coverage. The buyer should compare net premiums (gross premium minus commission) rather than gross premiums to make a fair comparison.

The sixth change is the renewal timeline. With more complex commission negotiations occurring between brokers and insurers, and more documentation required for disclosure compliance, the renewal process is taking longer than it used to. Mid-market companies that traditionally initiated their renewal 30 days before expiry are finding that this timeline is no longer sufficient. Best practice under the new regime is to begin the renewal process 60-90 days before the policy expiry date, allowing adequate time for the broker to approach multiple insurers, negotiate terms, provide commission disclosure, and give the buyer time to evaluate the options.

Finally, the reforms have created an opportunity for mid-market companies to professionalize their insurance procurement. The disclosure requirements give buyers information that was previously unavailable. The flexible commission structure gives buyers the ability to negotiate broker remuneration. And the composite licence framework gives buyers the option to simplify their programme structure. Companies that treat insurance as a strategic procurement decision, rather than an annual administrative chore, will extract the most value from these regulatory changes.

The 2025 reforms have shifted power toward commercial insurance buyers, but only for those who choose to exercise it. The disclosure requirements and commission flexibility create an environment where informed, assertive buyers can obtain better outcomes, while passive buyers may actually be worse off (because their brokers have more room to optimise for their own income rather than the client's interest). Here is a concrete list of what every commercial insurance buyer in India should demand from their broker under the new regulatory framework.

Demand one: a written broker mandate letter. Before the renewal process begins, establish the terms of the broker's engagement in writing. The mandate letter should specify the scope of services the broker will provide (placement only, or placement plus advisory, claims advocacy, risk engineering, and mid-term policy management), the number of insurers the broker will approach for each line of coverage (minimum three for any line with premium exceeding INR 10 lakh), the evaluation criteria for comparing quotations (price, coverage, insurer financial strength, claims track record), and the basis of broker remuneration (commission-based, fee-based, or hybrid).

Demand two: pre-placement commission disclosure at least 30 days before inception. The disclosure should be provided in a standardised format showing, for each policy class and each insurer on the panel, the expected commission percentage, any contingent or profit-share commission arrangement, and any volume-based incentive that the broker receives from the insurer across its total portfolio (not just the buyer's business). The disclosure should be specific, not vague. A disclosure stating 'brokerage will be between 10-20% depending on the insurer' is not useful. A disclosure stating 'Insurer A: 15%, Insurer B: 12%, Insurer C: 10%, with a 2% profit commission from Insurer A if portfolio loss ratio stays below 40%' is useful.

Demand three: a written placement recommendation report. After obtaining quotations and before binding coverage, the broker should provide a written report comparing the quotations on multiple dimensions: premium, coverage terms (including exclusions and sub-limits), insurer financial strength rating (from ICRA, CRISIL, or AM Best), the insurer's claims settlement ratio and average claims processing time, and any notable differences in policy wording. The report should include the broker's recommendation with a clear explanation of why the recommended insurer was selected. If the recommended insurer is also the one paying the highest commission, the broker should explain why the recommendation is justified on coverage and price grounds despite the commission differential.

Demand four: post-placement commission confirmation within 30 days of inception. The confirmation should state the actual commission earned, including any adjustments from the pre-placement disclosure. If the actual commission differs materially from the pre-placement disclosure (by more than 2 percentage points on any line), the broker should explain the reason for the deviation.

Demand five: annual portfolio review. At least once per year, the broker should provide a thorough review of the client's insurance portfolio covering all active policies, their terms and conditions, any coverage gaps identified, claims experience for the preceding year, premium benchmarking against industry norms, and recommendations for coverage adjustments at the next renewal. This review should be a substantive working document, not a glossy presentation with generic market commentary.

Demand six: claims advocacy commitment. Commission reform has increased the risk that brokers will focus their energy on placement (where they earn commission) at the expense of claims service (where they earn nothing incrementally). The broker mandate letter should include specific commitments on claims service: acknowledgement within 24 hours of claim notification, assignment of a named claims handler, regular progress updates, and active advocacy with the insurer on coverage and quantum disputes.

Demand seven: right to audit. The broker mandate letter should reserve the buyer's right to audit the broker's records relating to the buyer's account, including commission receipts, insurer correspondence, and quotation records. This right is rarely exercised, but its existence acts as a deterrent against non-disclosure.

Demand eight: a clear conflict of interest policy. Ask the broker to provide their written policy on managing conflicts of interest, including placement steering, contingent commissions, and relationships with insurers where the broking firm or its principals have an ownership or board-level connection. This is particularly relevant in the Indian market, where some broking firms are owned by or affiliated with insurance companies.

Demand nine: benchmarking data. Request that your broker provide premium benchmarking data showing how your rates compare to similar companies in your industry and region. Under the old regime, brokers had little incentive to provide this data because it might reveal that the placement was not competitive. Under the new regime, where commission transparency creates accountability, buyers should expect their broker to demonstrate that the premium being charged is market-appropriate. Several Indian broking firms now subscribe to benchmarking databases or maintain internal rate indices; ask your broker whether they have access to such data and request it as part of the annual portfolio review.

Demand ten: succession and continuity planning. For mid-market companies that rely heavily on their broker's institutional knowledge of the company's risk profile, ask the broker to maintain a documented risk profile and coverage history that can be transferred to a replacement broker if the relationship ends. This protects the buyer from losing years of accumulated programme knowledge if the key relationship manager leaves the broking firm or if the buyer decides to change brokers.

These demands are not adversarial. They are the baseline expectations that any professional intermediary should meet. Brokers who resist these requirements are signalling that their business model depends on information asymmetry, not on service quality. Buyers who implement these demands will find that their insurance programme improves in coverage quality, their premiums become more competitive, and their broker's advice becomes more trustworthy.

Looking beyond the immediate impact on renewal cycles and broker negotiations, the 2025 commission reforms are likely to reshape the structure of Indian insurance distribution over the next five to ten years. The direction of change is visible in markets that underwent similar deregulation decades earlier, particularly the UK, Australia, and to some extent the United States. While India's market has unique characteristics that will modify the outcomes, the underlying economic forces are similar.

The first structural shift is broker consolidation. When commissions are flexible and volume-based incentives are permitted, larger brokers have a structural advantage: they can negotiate higher commissions from insurers because they control more premium volume, and they can cross-subsidise low-margin placements with high-margin ones across their portfolio. This volume advantage creates pressure on smaller brokers, who cannot match the commission deals available to larger firms. In the UK, this dynamic contributed to the consolidation of the broking market over the 2000s and 2010s, resulting in a market dominated by a handful of large national and international firms, with smaller brokers surviving primarily in niche segments.

In India, this consolidation is already underway. The largest broking firms (Marsh, Aon, WTW, Gallagher, and their Indian counterparts) are acquiring smaller firms to build scale, expand geographic coverage, and capture portfolio-level commission deals. For commercial insurance buyers, broker consolidation has mixed implications. Larger broking firms bring broader expertise, stronger insurer relationships, and more sophisticated analytics. But they also bring higher overhead costs (which must be recovered through commissions), more complex internal structures (which can slow decision-making and reduce personalised service), and a greater distance between the relationship manager and the client (the partner who wins the account is rarely the person who services it day-to-day).

Mid-market companies, which often value the personal relationship and local presence of a smaller broker, may find that their preferred broker is acquired by a larger firm. If this happens, buyers should evaluate whether the acquirer will maintain the service level they received from the original broker, or whether they will be treated as a small account within a large portfolio.

The second structural shift is the growth of fee-based advisory. As commission disclosure makes the cost of intermediation visible, a growing number of commercial insurance buyers will question whether commission-based remuneration aligns the broker's incentives with theirs. The alternative, fee-based advisory, has been the norm in mature markets for large commercial and industrial accounts for decades. In the UK, the majority of FTSE 250 companies pay their broker on a fee basis. In India, fee-based arrangements have been rare outside the top 100 corporates, primarily because buyers were unaware of the commission amounts involved and did not see the value proposition of paying an explicit fee.

The 2025 disclosure requirements change this calculus. When a mid-market company discovers that its broker earned INR 15 lakh in commission on a INR 1 crore premium, and that a fee-based arrangement would cost INR 5 lakh with the remaining INR 10 lakh returned as a premium credit, the economic argument for fee-based advisory becomes compelling. The growth of fee-based models will be gradual, limited initially to larger mid-market companies and sectors with sophisticated procurement functions. But over five to ten years, fee-based advisory is likely to become the norm for any company with annual premium exceeding INR 50 lakh.

The third structural shift is the rise of technology-enabled distribution. The commission reforms arrive at a time when insurtech platforms are expanding into commercial insurance distribution in India. These platforms use technology to automate the quotation, comparison, and placement process, reducing the need for manual broker intervention on standard products. For commodity commercial products (standard fire, group health, motor fleet), technology platforms can offer lower-cost distribution with built-in commission transparency, because the platform's commission structure is visible in its pricing.

For complex commercial risks (multi-location property programmes, liability towers, niche industry covers), technology cannot replace human expertise. But it can augment the broker's capabilities by providing data analytics, market comparison tools, and automated compliance documentation. The brokers that will thrive in the post-reform environment are those that combine human expertise with technology infrastructure, using analytics to support their advisory recommendations and automated tools to handle the administrative burden of disclosure, documentation, and compliance.

The fourth structural shift is increased regulatory sophistication. IRDAI's transition from prescriptive regulation (setting commission caps) to principles-based regulation (requiring disclosure, managing total expenses at the insurer level) reflects a maturing regulatory approach. Over time, this creates space for market innovation but also places greater responsibility on market participants to self-regulate. If placement steering becomes widespread and buyer complaints increase, IRDAI will likely respond with additional conduct regulation, potentially including mandatory independent audits of broker placements, standardised quotation formats, or restrictions on contingent commissions. The market's behaviour in the first two to three years of the new regime will determine whether IRDAI's principles-based approach is sustainable or whether more prescriptive intervention follows.

The fifth structural shift is improved claims outcomes. This may seem unrelated to commission reform, but the connection is direct. When brokers earn their income through commission on premium placement, their economic incentive is to maximise placed premium, not to maximise claims recoveries. Fee-based brokers, whose income is independent of premium volume, have a stronger incentive to advocate aggressively on claims, because claims performance is the primary metric by which their clients judge value. As fee-based advisory grows, the quality of claims advocacy across the Indian commercial insurance market should improve, leading to better outcomes for policyholders and, indirectly, reducing the trust deficit that has historically characterised the insurance industry in India.

For commercial insurance buyers watching these developments, the message is clear: the 2025 reforms are not a one-time adjustment but the beginning of a multi-year transformation in how insurance is distributed, priced, and serviced in India. Buyers who engage proactively with these changes, by demanding transparency, evaluating alternative remuneration models, and holding their brokers to higher standards, will be the primary beneficiaries.